TAVI for Pure Native Aortic Regurgitation: Are We There Yet?
Treatment of degenerative aortic stenosis has been transformed by transcatheter aortic valve implantation (TAVI) over the past 10–15 years. The success of various technologies has led operators to attempt to broaden the indications, and many patients with native valve aortic regurgitation have been...
Guardado en:
Autores principales: | Eduardo A Arias, Amit Bhan, Zhan Y Lim, Michael Mullen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5385acb4978d4c92bb8a9ea3d92f8645 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cerebral Embolic Protection in TAVI: Friend or Foe
por: Michael Teitelbaum, et al.
Publicado: (2019) -
How to Make the TAVI Pathway More Efficient
por: Didier Tchetche, et al.
Publicado: (2019) -
Moderate Aortic Stenosis: What is it and When Should We Intervene?
por: Sveeta Badiani, et al.
Publicado: (2021) -
New Challenging Scenarios in Transcatheter Aortic Valve Implantation: Valve-in-valve, Bicuspid and Native Aortic Regurgitation
por: Sandra Santos-Martínez, et al.
Publicado: (2021) -
Corrigendum to: Management of Tricuspid Regurgitation: The Role of Transcatheter Therapies
por: Maurizio Taramasso, et al.
Publicado: (2020)